[1]
Drent, M. et al. 2016. Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action.
Sarcoidosis, Vasculitis and Diffuse Lung Diseases
. 33, 2 (Aug. 2016), 191–194.